236 related articles for article (PubMed ID: 37431060)
1. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
3. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
4. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij BH; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
[TBL] [Abstract][Full Text] [Related]
5. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.
Studahl M; Rosengren L; Günther G; Hagberg L
J Neurol; 2000 Aug; 247(8):636-42. PubMed ID: 11041333
[TBL] [Abstract][Full Text] [Related]
6. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
[TBL] [Abstract][Full Text] [Related]
7. Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Mañé-Martínez MA; Olsson B; Bau L; Matas E; Cobo-Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
J Neuroimmunol; 2016 Oct; 299():112-117. PubMed ID: 27725108
[TBL] [Abstract][Full Text] [Related]
8. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
9. Serum and cerebrospinal fluid phosphorylated neurofilament heavy subunit as a marker of neuroaxonal damage in tick-borne encephalitis.
Fortova A; Hönig V; Palus M; Salat J; Pychova M; Krbkova L; Vyhlidalova T; Kriha MF; Chrdle A; Ruzek D
J Gen Virol; 2022 May; 103(5):. PubMed ID: 35506983
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome.
Lindström J; Grahn A; Zetterberg H; Studahl M
Eur J Neurosci; 2016 Dec; 44(11):2944-2949. PubMed ID: 27643680
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
Eckerström M; Nilsson S; Zetterberg H; Blennow K; Grahn A
Sci Rep; 2020 Dec; 10(1):22400. PubMed ID: 33372192
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.
Grahn A; Hagberg L; Nilsson S; Blennow K; Zetterberg H; Studahl M
J Neurol; 2013 Jul; 260(7):1813-21. PubMed ID: 23471614
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
15. Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury.
Andersson E; Öst M; Dalla K; Zetterberg H; Blennow K; Nellgård B
Neurocrit Care; 2024 May; ():. PubMed ID: 38769253
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
[TBL] [Abstract][Full Text] [Related]
17. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Day GS; Yarbrough MY; Körtvelyessy P; Prüss H; Bucelli RC; Fritzler MJ; Mason W; Tang-Wai DF; Steriade C; Hébert J; Henson RL; Herries EM; Ladenson JH; Lopez-Chiriboga AS; Graff-Radford NR; Morris JC; Fagan A
Neurology; 2021 May; 96(20):e2546-e2557. PubMed ID: 33795390
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
